2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

7- Infections and Other Lessons Learned after IntestineTransplantation

32.12 - Limits for Pediatric Intestinal Re-Transplantation

Presenter: Francisco, Hernandez Oliveros, madrid, Spain
Authors: Francisco Hernández, Ane Miren Andrés, Vanessa Núñez, Paloma Triana, José Luis Encinas, Alba Sánchez, Carlos De La Torre, Manuel Gámez, Esther Ramos, Lorena Magallares, Jesús Sarria, Gerardo Prieto, Manuel López-Santamaría

Limits for Pediatric Intestinal Re-Transplantation

Francisco Hernández1, Ane Miren Andrés1, Vanessa Núñez1, Paloma Triana1, José Luis Encinas1, Alba Sánchez1, Carlos De La Torre1, Manuel Gámez1, Esther Ramos2, Lorena Magallares2, Jesús Sarria2, Gerardo Prieto2, Manuel López-Santamaría1.

1Pediatric Surgery, La Paz University Hospital, Madrid, Spain; 2Pediatric Gastroenterology, La Paz University Hospital, Madrid, Spain

Aim: Intestinal re-transplantation (Re-IT) is becoming a relatively common procedure as the number of long term survivors increases. However, no clear consensus has been achieved regarding the limits for Re-IT. Our aim was to analyze the results of intestinal re-transplantation.

Patients and Method: We retrospectively reviewed the records of pediatric patients who underwent Re-IT at our center (1999-2017). Survival, type of primary and subsequent grafts was included in the analysis.

Results: A total of 100 intestinal transplants were performed (1999-2017) in 79 patients. RE-IT were performed in 15 patients: 9 required a second graft, and 6 received a third graft. Distribution by type of primary and subsequent graft was as follows: SB-MVT (7), SB-SB-MV (5), SB-MV-MV (1), SB-CLSB (1), CLSB-CLSB (1) and MV-MV (1). Of the 6 patients that received a third graft, 5 had a previous isolated bowel and 1 had a MV graft, all of them underwent Re-TI with a MV graft. The 5 patients that underwent RE-IT with an isolated bowel required a third graft. Causes of primary graft loss were ACR (12) (+DSA, 2), CR (2) (+DSA, 2) and lymphoma (1); while causes for secondary graft lost were ACR (3) (+DSA, 2), CR (1) (+DSA, 1) and malignancy (2). Overall survival of RE-IT and non RE-IT patients were 60% and 64% respectively. No patient survived RE-IT when the previous graft included the liver (2MV-MV and 1CLSB-MV)

Conclusions: In our experience, survival after RE-IT was comparable to long term survival of our main series.
However, RE-IT with an isolated bowel graft ended up in graft lost in all cases, and no patient survived RE-Tx in the long term when the previous graft included the liver.
The limited number of cases warrants further research before recommendations regarding the limits of RE-IT can be defined.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada